Strides Pharma Science

Strides Pharma Science Short-term Debt

The Short-Term Debt of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 11.36 B INR. In the previous year, Short-Term Debt was 15.74 B INR — a change of -27.81% (lower).

Short-term Debt

11.36 BINR

YoY

-27.81%

Last updated:

Short-Term Debt of Strides Pharma Science is 2025 11.36 B INR. Short-Term Debt of Strides Pharma Science was 2024 15.74 B INR. It decreases by -27.81% lower compared to the previous year.

The Strides Pharma Science Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2018
9.44 B INR
Jan 1, 2019
13.39 B INR
Jan 1, 2020
12.29 B INR
Jan 1, 2021
10.24 B INR
Jan 1, 2022
14.97 B INR
Jan 1, 2023
13.31 B INR
Jan 1, 2024
15.74 B INR
Jan 1, 2025
11.36 B INR
The Strides Pharma Science Short-term Debt history
YEARShort-term DebtYoY
11.36 BINR-27.81%
15.74 BINR+18.29%
13.31 BINR-11.08%
14.97 BINR+46.17%
10.24 BINR-16.68%
12.29 BINR-8.23%
13.39 BINR+41.78%
9.44 BINR-32.25%
13.94 BINR+99.00%
7.01 BINR+245.07%
2.03 BINR-9.62%
2.25 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Strides Pharma Science stock

Short-Term Debt of Strides Pharma Science is 11.36 B INR in 2025.

Short-Term Debt of Strides Pharma Science changed from 15.74 B INR to 11.36 B INR, representing a -27.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Strides Pharma Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Strides Pharma Science

All Key Metrics — Strides Pharma Science